Skip to content
777 Sourcing.

Capability

multi-omics approach

Suppliers
1
States & provinces
1
Countries
1

1 multi-omics approach supplier across 1 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

CELLEPUS THERAPEUTICS, INC.

ROCKVILLE, MD

Cellepus Therapeutics is a cell therapy company developing off-the-shelf, allogeneic γδ1/3 CAR-T cells designed to treat solid tumors. Its platform uses a proprietary 'Zeta-less' CAR signaling architecture to resist exhaustion, tumor-specific antigen targets, and scalable manufacturing using cord blood.

allogeneic cell therapyCAR-T cell engineeringscalable manufacturing using cord bloodtumor antigen discovery

Compiled from public sources

Related capabilities

Other processes offered by the shops that list multi-omics approach.

Browse all capabilities